24/7 Market News Snapshot 18 August, 2025 – OneMedNet Corp Class A Common Stock (NASDAQ:ONMD)
DENVER, Colo., 18 August, 2025 (www.247marketnews.com) – (NASDAQ:ONMD) are discussed in this article.
OneMedNet Corporation has experienced a significant surge in its Class A Common Stock (ONMD), climbing from an opening price of $0.676 to a current trading value of $0.862, marking an increase of over 34.2% with a trading volume of 12.49 million shares. This impressive movement follows a closing price of $0.642 in the previous session, which indicates a strong bullish trend and growing investor interest in the company. Such market activity suggests potential for heightened engagement in OneMedNet’s offerings, making it critical for investors to keep a close watch on further developments.
In a strategic move, OneMedNet has also announced a long-term partnership with Circle Cardiovascular Imaging Inc. (Circle CVI), which is renowned for its advancements in cardiovascular imaging technology. This collaboration aims to leverage OneMedNet’s AI-powered Real-World Data (RWD) platform, specifically the iRWD™ system, to provide Circle CVI with secure access to a comprehensive database of regulatory-grade cardiovascular data. This includes imaging and ECG information derived from more than 1,750 provider sites and over 131 million exams.
Circle CVI plans to utilize this wealth of high-quality data to enhance the development and validation of AI-driven models, crucial for advancing cardiac diagnostics and treatment planning. Circle CVI’s CEO, Erkan Akyuz, expressed enthusiasm about the partnership, noting the outstanding quality of OneMedNet’s data. Similarly, OneMedNet’s President and CEO, Aaron Green, highlighted the significance of this collaboration, which not only underscores the value of their Real-World Data but also reflects an industry-wide trend towards employing real-world evidence to foster innovation in healthcare. Together, these developments signify a transformative phase in cardiovascular care, promoting better patient outcomes through state-of-the-art imaging solutions and data analytics.